Business Context and Reporting Period
Company: Griffin-American Healthcare REIT IV, Inc. (American Healthcare REIT, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: March 31, 2020 (Event Date: April 2-3, 2020)
Context: The filing announces the Board's determination of an estimated Net Asset Value (NAV) per share, updates to the Distribution Reinvestment Plan (DRIP) and Share Repurchase Plan (SRP), and outlines the Company's response to the emerging COVID-19 pandemic. The valuation is based on data as of December 31, 2019, prior to the widespread impact of the pandemic in the United States.
Key Financial Metrics
Estimated Net Asset Value (NAV): $9.54 per share (Class T and Class I common stock) as of December 31, 2019.
Total Estimated Asset Value: $1,130,167,000 (Appraised Properties and Other Properties).
Total Debt Liabilities: $421,055,000.
Cash and Other Assets: $77,724,000.
Fully Diluted Shares Outstanding: 79,899,874.
Annualized Distribution Rate: Reduced to $0.40 per share (from $0.60 per share).
Valuation Firm: Jones Lang LaSalle Securities, LLC (JLLS).
Material Changes vs. Prior Period
- NAV Stability: The estimated NAV of $9.54 per share remains unchanged from the December 31, 2018 valuation, despite an increase in the aggregate value of appraised properties from $915.6 million (2018) to $1.13 billion (2019). This stability is attributed to a corresponding increase in debt liabilities and share count.
- Debt Increase: Debt liabilities increased from $292.0 million in 2018 to $421.1 million in 2019.
- Share Count Increase: Fully diluted shares outstanding increased from approximately 69.3 million in 2018 to 79.9 million in 2019.
- Valuation Methodology: The Company switched valuation firms from CBRE Capital Advisors, Inc. to JLLS for the 2019 assessment.
Guidance, Outlook, and Management Commentary
COVID-19 Impact: Management emphasizes that the $9.54 NAV was calculated prior to the emergence of COVID-19 in the U.S. The Board acknowledges that the pandemic may have a significant and uncertain impact on asset values, tenants, and operators. The Company is continuously monitoring the situation and may be required to reevaluate the NAV sooner than the annual schedule if the pandemic causes a material adverse impact.
Distribution Reduction: To protect capital and maximize liquidity, the Board reduced the daily distribution rate effective April 1, 2020. The new annualized rate is $0.40 per share, down from $0.60 per share.
Share Repurchase Plan (SRP) Suspension: The Board partially suspended the SRP effective for requests submitted in the second quarter of 2020. Repurchases are now limited to cases involving the death or qualifying disability of a stockholder. The Board retains discretion to reinstate the plan based on the Company's best interests.
Valuation Range: JLLS provided a valuation range of $9.28 to $9.99 with a mid-point of $9.75. The Board elected to set the NAV at $9.54 (the lower end of the range) to account for pandemic-related uncertainties.
Investor Verification Checklist
- Verify the specific terms of the reduced distribution rate ($0.40 annualized) and payment schedule for May 2020.
- Confirm the eligibility criteria for the suspended Share Repurchase Plan (limited to death or qualifying disability).
- Review the sensitivity analysis regarding discount rates and capitalization rates, noting that a 2.5% change could alter the NAV by approximately $0.16 to $0.21 per share.
- Monitor future filings for updates on the impact of COVID-19 on tenant occupancy, lease terms, and potential asset value re-evaluations.
- Understand that the $9.54 NAV is an estimate based on pre-pandemic data and does not represent a guaranteed liquidation value or trading price.